+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Middle East Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), Study Design, Indication, Indication by Study Design, Service, Sponsor, and Country with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 180 Pages
  • September 2025
  • Region: Middle East
  • Grand View Research
  • ID: 6176784
REQUEST CUSTOMIZATION
Description Jump to:
The Middle East clinical trials market size was estimated at USD 671.57 Million in 2025 and is projected to reach USD 1.16 billion by 2033, growing at a CAGR of 7.18% from 2025 to 2033. The Middle East faces a rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, obesity, and cancer, creating strong demand for new therapies.

Countries like Saudi Arabia, UAE, and Qatar report some of the world’s highest diabetes rates, making them prime locations for trials targeting metabolic and lifestyle-related conditions. According to the Telecommunications and Digital Government Regulatory Authority 2024, as of 2021, diabetes affected 11.8% of the UAE population. Reducing its prevalence remains a key performance indicator under the world-class healthcare pillar of the UAE National Agenda 2021. This growing disease burden drives pharmaceutical companies to establish local clinical studies to test the efficacy of novel drugs on region-specific populations. The urgent need for better therapeutic options also ensures government and healthcare sector support, fueling market expansion in the region.

Middle Eastern governments are prioritizing research and innovation to strengthen healthcare systems and diversify economies. Saudi Arabia’s Vision 2030, UAE’s Centennial 2071, and Qatar’s National Health Strategy all emphasize clinical research, digital health, and partnerships with global pharma firms. Regulatory reforms are streamlining trial approvals, while infrastructure investments expand research centers and trial sites. Setting up clinical trials in the Middle East offers sponsors higher patient recruitment and stronger investigator engagement compared to traditional hubs. Conducting trials in regions with unmet clinical needs enhances access, optimizes efficiency, and supports innovation, especially when combined with AI and real-world data integration for regulatory submissions.

The adoption of reliance models and harmonized regulatory frameworks across the Gulf Cooperation Council (GCC) and Arab Regulators Network is a strong growth driver. Saudi Arabia’s SFDA and Qatar’s Ministry of Public Health are advancing regulatory reforms to align with global standards through reliance practices, digitalization, and collaboration. Efforts include streamlined approvals, pharmacovigilance, and AI integration. By referencing approvals from trusted agencies like the US FDA, EMA, or regional peers, Middle Eastern regulators accelerate the review and approval of clinical trials and new therapies. This harmonization reduces duplication, shortens approval timelines, and enhances confidence among international sponsors. Combined with digital regulatory platforms and cross-border collaborations, these practices strengthen efficiency and ensure high safety and quality standards, making the Middle East an increasingly attractive destination for global clinical research.

Public-private partnerships further attract foreign investment. For instance, in December 2024, Uncommon Cures partnered with UAE-based Carexso and PDC FZ LLC to accelerate orphan drug clinical trials in the Middle East. Combining expertise in rare disease drug development with regional infrastructure, this collaboration aimed to streamline regulatory pathways, expand access, and deliver innovative therapies to underserved rare disease patients. This supportive environment encourages both multinational and regional companies to conduct clinical trials, positioning the Middle East as an emerging hub for pharmaceutical innovation and life sciences research.

The Middle East region has seen rapid development in healthcare and research infrastructure, including modern hospitals, advanced laboratories, and specialized research institutes. Leading Contract Research Organizations (CROs) and local clinical research units are expanding operations in countries such as Saudi Arabia, the UAE, and Egypt, bringing global expertise and technology. The availability of electronic health records, biobanks, and genomic research initiatives further enhances trial efficiency. This robust infrastructure supports complex trials, from Phase I to Phase IV, while ensuring compliance with international standards. As a result, more pharmaceutical companies are choosing the Middle East for high-quality, large-scale clinical studies.

Middle East Clinical Trials Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the Middle East clinical trials market report based on phase, study design, indication, indication by study design, service, sponsor, and country:

Phase Outlook (Revenue, USD Million, 2021-2033)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Study Design Outlook (Revenue, USD Million, 2021-2033)

  • Interventional Trials
  • Observational Trials
  • Expanded Access Trials

Indication Outlook (Revenue, USD Million, 2021-2033)

  • Autoimmune/Inflammation
  • Pain Management
  • Oncology
  • CNS Conditions
  • Diabetes
  • Obesity
  • Cardiovascular Diseases
  • Others

Indication by Study Design Outlook (Revenue, USD Million, 2021-2033)

  • Autoimmune/Inflammation
  • Pain Management
  • Oncology
  • CNS Conditions
  • Diabetes
  • Obesity
  • Cardiovascular Diseases
  • Others

Service Outlook (Revenue, USD Million, 2021-2033)

  • Protocol Designing
  • Site Identification
  • Patient Recruitment
  • Laboratory Services
  • Analytical Testing Services
  • Clinical Trial Data Management Services
  • Others

Sponsor Outlook (Revenue, USD Million, 2021-2033)

  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Others

Country Outlook (Revenue, USD Million, 2021-2033)

  • Middle East

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Value chain based analysis (Model 2)
1.7.3. Multivariate Analysis (Model 3)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Middle East Clinical Trials Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.2.3. Market Challenge Analysis
3.3. R&D Spending Analysis
3.3.1. R&D Investment Analysis, by Key Sponsors (2021-2024)
3.3.2. Venture Capital & Government Funding Scenario
3.4. Middle East Clinical Trials Design Analysis
3.5. Industry Ecosystem Analysis
3.6. Technology Landscape
3.7. Clinical Trial Volume Analysis, 2024
3.7.1. Total Number of Middle East Clinical Trials, by Region (2024)
3.7.2. Total Number of Middle East Clinical Trials, by Phase (2024)
3.7.3. Total Number of Middle East Clinical Trials, by Study Design (2024)
3.7.4. Total Number of Middle East Clinical Trials, by Key Indication (2024)
3.8. Middle East Clinical Trials Market Analysis Tools
3.8.1. Porter’s Five Forces Analysis
3.8.2. PESTEL by SWOT Analysis
Chapter 4. Middle East Clinical Trials Market: Phase Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Middle East Clinical Trials Market: Phase Movement Analysis
4.3. Middle East Clinical Trials Market Estimates and Forecasts, by Phase, 2021-2033 (USD Million)
4.4. Phase I
4.4.1. Phase I Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Phase II
4.5.1. Phase II Market Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Phase III
4.6.1. Phase III Market Estimates and Forecasts, 2021-2033 (USD Million)
4.7. Phase IV
4.7.1. Phase IV Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Middle East Clinical Trials Market: Study Design Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Middle East Clinical Trials Market: Study Design Movement Analysis
5.3. Middle East Clinical Trials Market Estimates and Forecasts, by Study Design, 2021-2033 (USD Million)
5.4. Interventional trials
5.4.1. Interventional Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Observational trials
5.5.1. Observational Market Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Expanded Access trials
5.6.1. Expanded Access Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Middle East Clinical Trials Market: Indication Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Middle East Clinical Trials Market: Indication Movement Analysis
6.3. Middle East Clinical Trials Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
6.4. Autoimmune/Inflammation
6.4.1. Autoimmune/Inflammation Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.2. Rheumatoid Arthritis
6.4.2.1. Rheumatoid Arthritis Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.3. Multiple Sclerosis
6.4.3.1. Multiple Sclerosis Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.4. Osteoarthritis
6.4.4.1. Osteoarthritis Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.5. Irritable Bowel Syndrome (IBS)
6.4.5.1. Irritable Bowel Syndrome (IBS) Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.6. Others
6.4.6.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Pain Management
6.5.1. Pain Management Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.2. Chronic Pain
6.5.2.1. Chronic Pain Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.3. Acute Pain
6.5.3.1. Acute Pain Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Oncology
6.6.1. Oncology Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.2. Blood Cancer
6.6.2.1. Blood Cancer Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.3. Solid Tumors
6.6.3.1. Solid Tumors Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.4. Others
6.6.4.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. CNS Conditions
6.7.1. CNS Conditions Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.2. Epilepsy
6.7.2.1. Epilepsy Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.3. Parkinson's Disease (PD)
6.7.3.1. Parkinson's Disease (PD) Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.4. Huntington's Disease
6.7.4.1. Huntington's Disease Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.5. Stroke
6.7.5.1. Stroke Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.6. Traumatic Brain Injury (TBI)
6.7.6.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.7. Amyotrophic Lateral Sclerosis (ALS)
6.7.7.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.8. Muscle Regeneration
6.7.8.1. Muscle Regeneration Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.9. Others
6.7.9.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
6.8. Diabetes
6.8.1. Diabetes Market Estimates and Forecasts, 2021-2033 (USD Million)
6.9. Obesity
6.9.1. Obesity Market Estimates and Forecasts, 2021-2033 (USD Million)
6.10. Cardiovascular Diseases
6.10.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
6.11. Others
6.11.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Middle East Clinical Trials Market: Indication by Study Design Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Middle East Clinical Trials Market: Indication by Study Design Movement Analysis
7.3. Middle East Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2021-2033 (USD Million)
7.4. Autoimmune/Inflammation
7.4.1. Autoimmune/Inflammation Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.2. Interventional Trials
7.4.2.1. Interventional Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.3. Observational Trials
7.4.3.1. Observational Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.4. Expanded Access Trials
7.4.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Pain Management
7.5.1. Pain Management Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.2. Interventional Trials
7.5.2.1. Interventional Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.3. Observational Trials
7.5.3.1. Observational Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.4. Expanded Access Trials
7.5.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Oncology
7.6.1. Oncology Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.2. Interventional Trials
7.6.2.1. Interventional Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.3. Observational Trials
7.6.3.1. Observational Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.4. Expanded Access Trials
7.6.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7. CNS Conditions
7.7.1. CNS Conditions Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.2. Interventional Trials
7.7.2.1. Interventional Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.3. Observational Trials
7.7.3.1. Observational Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.4. Expanded Access Trials
7.7.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8. Diabetes
7.8.1. Diabetes Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.2. Interventional Trials
7.8.2.1. Interventional Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.3. Observational Trials
7.8.3.1. Observational Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.4. Expanded Access Trials
7.8.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.9. Obesity
7.9.1. Obesity Market Estimates and Forecasts, 2021-2033 (USD Million)
7.9.2. Interventional Trials
7.9.2.1. Interventional Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.9.3. Observational Trials
7.9.3.1. Observational Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.9.4. Expanded Access Trials
7.9.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.10. Cardiovascular Diseases
7.10.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
7.10.2. Interventional Trials
7.10.2.1. Interventional Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.10.3. Observational Trials
7.10.3.1. Observational Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.10.4. Expanded Access Trials
7.10.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.11. Others
7.11.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
7.11.2. Interventional Trials
7.11.2.1. Interventional Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.11.3. Observational Trials
7.11.3.1. Observational Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
7.11.4. Expanded Access Trials
7.11.4.1. Expanded Access Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Middle East Clinical Trials Market: Service Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Middle East Clinical Trials Market: Service Movement Analysis
8.3. Middle East Clinical Trials Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
8.4. Protocol Designing
8.4.1. Protocol Designing Market Estimates and Forecasts, 2021-2033 (USD Million)
8.5. Site Identification
8.5.1. Site Identification Market Estimates and Forecasts, 2021-2033 (USD Million)
8.6. Patient Recruitment
8.6.1. Patient Recruitment Market Estimates and Forecasts, 2021-2033 (USD Million)
8.7. Laboratory Services
8.7.1. Laboratory Services Market Estimates and Forecasts, 2021-2033 (USD Million)
8.8. Analytical Testing Services
8.8.1. Analytical Testing Services Market Estimates and Forecasts, 2021-2033 (USD Million)
8.9. Clinical Trial Data Management Services
8.9.1. Clinical Trial Data Management Services Market Estimates and Forecasts, 2021-2033 (USD Million)
8.10. Others
8.10.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. Middle East Clinical Trials Market: Sponsor Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Middle East Clinical Trials Market: Sponsor Movement Analysis
9.3. Middle East Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021-2033 (USD Million)
9.4. Pharmaceutical & Biopharmaceutical Companies
9.4.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
9.5. Medical Device Companies
9.5.1. Medical Device Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
9.6. Others
9.6.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 10. Middle East Clinical Trials Market: Regional Estimates & Trend Analysis
10.1. Regional Outlook
10.2. Middle East Clinical Trials Market: Regional Movement Analysis
10.3. Middle East Clinical Trials Market Estimates and Forecasts, by region, 2021-2033 (USD Million)
10.3.1. Saudi Arabia
10.3.1.1. Key Country Dynamics
10.3.1.2. Competitive Scenario
10.3.1.3. Regulatory Framework
10.3.1.4. Saudi Arabia Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
10.3.2. UAE
10.3.2.1. Key Country Dynamics
10.3.2.2. Competitive Scenario
10.3.2.3. Regulatory Framework
10.3.2.4. UAE Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
10.3.3. Kuwait
10.3.3.1. Key Country Dynamics
10.3.3.2. Competitive Scenario
10.3.3.3. Regulatory Framework
10.3.3.4. Kuwait Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
10.3.4. Oman
10.3.4.1. Key Country Dynamics
10.3.4.2. Competitive Scenario
10.3.4.3. Regulatory Framework
10.3.4.4. Oman Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
10.3.5. Qatar
10.3.5.1. Key Country Dynamics
10.3.5.2. Competitive Scenario
10.3.5.3. Regulatory Framework
10.3.5.4. Qatar Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 11. Competitive Landscape
11.1. Company Categorization
11.1.1. Innovators
11.1.2. Market Leaders
11.1.3. Emerging Players
11.2. Company Market Assessment Analysis, 2024 (Company Heat Map Analysis)
11.3. Key Company Profiles
11.3.1. Sanofi
11.3.1.1. Company Overview
11.3.1.2. Financial Performance
11.3.1.3. Service Benchmarking
11.3.1.4. Strategic Initiatives
11.3.2. Novartis AG
11.3.2.1. Company Overview
11.3.2.2. Financial Performance
11.3.2.3. Service Benchmarking
11.3.2.4. Strategic Initiatives
11.3.3. Pfizer
11.3.3.1. Company Overview
11.3.3.2. Financial Performance
11.3.3.3. Service Benchmarking
11.3.3.4. Strategic Initiatives
11.3.4. GSK plc
11.3.4.1. Company Overview
11.3.4.2. Financial Performance
11.3.4.3. Service Benchmarking
11.3.4.4. Strategic Initiatives
11.3.5. Novo Nordisk A/S
11.3.5.1. Company Overview
11.3.5.2. Financial Performance
11.3.5.3. Service Benchmarking
11.3.5.4. Strategic Initiatives
11.3.6. Hikma Pharmaceuticals PLC
11.3.6.1. Company Overview
11.3.6.2. Financial Performance
11.3.6.3. Service Benchmarking
11.3.6.4. Strategic Initiatives
11.3.7. Julphar
11.3.7.1. Company Overview
11.3.7.2. Financial Performance
11.3.7.3. Service Benchmarking
11.3.7.4. Strategic Initiatives
11.3.8. SPIMACO
11.3.8.1. Company Overview
11.3.8.2. Financial Performance
11.3.8.3. Service Benchmarking
11.3.8.4. Strategic Initiatives
11.3.9. Tabuk Pharmaceuticals
11.3.9.1. Company Overview
11.3.9.2. Financial Performance
11.3.9.3. Service Benchmarking
11.3.9.4. Strategic Initiatives
11.3.10. F. Hoffmann-La Roche Ltd
11.3.10.1. Company Overview
11.3.10.2. Financial Performance
11.3.10.3. Service Benchmarking
11.3.10.4. Strategic Initiatives
11.3.11. Johnson & Johnson
11.3.11.1. Company Overview
11.3.11.2. Financial Performance
11.3.11.3. Service Benchmarking
11.3.11.4. Strategic Initiatives
11.4. List of Other Key Market Players
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Middle East Clinical Trials Market Estimates and Forecasts, by Phase, 2021-2033 (USD Million)
Table 4 Middle East Clinical Trials Market Estimates and Forecasts, by Study Design, 2021-2033 (USD Million)
Table 5 Middle East Clinical Trials Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 6 Middle East Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021-2033 (USD Million)
Table 7 Middle East Clinical Trials Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 8 Middle East Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021-2033 (USD Million)
Table 9 Middle East Clinical Trials Market Estimates and Forecasts, by Region, 2021-2033 (USD Million)
Table 10 UAE Clinical Trials Market Estimates and Forecasts, by Phase, 2021-2033 (USD Million)
Table 11 UAE Clinical Trials Market Estimates and Forecasts, by Study Design, 2021-2033 (USD Million)
Table 12 UAE Clinical Trials Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 13 UAE Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021-2033 (USD Million)
Table 14 UAE Clinical Trials Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 15 UAE Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021-2033 (USD Million)
Table 16 Saudi Arabia Clinical Trials Market Estimates and Forecasts, by Phase, 2021-2033 (USD Million)
Table 17 Saudi Arabia Clinical Trials Market Estimates and Forecasts, by Study Design, 2021-2033 (USD Million)
Table 18 Saudi Arabia Clinical Trials Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 19 Saudi Arabia Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021-2033 (USD Million)
Table 20 Saudi Arabia Clinical Trials Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 21 Saudi Arabia Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021-2033 (USD Million)
Table 22 Kuwait Clinical Trials Market Estimates and Forecasts, by Phase, 2021-2033 (USD Million)
Table 23 Kuwait Clinical Trials Market Estimates and Forecasts, by Study Design, 2021-2033 (USD Million)
Table 24 Kuwait Clinical Trials Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 25 Kuwait Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021-2033 (USD Million)
Table 26 Kuwait Clinical Trials Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 27 Kuwait Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021-2033 (USD Million)
Table 28 Oman Clinical Trials Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 29 Oman Clinical Trials Market Estimates and Forecasts, by Phase, 2021-2033 (USD Million)
Table 30 Oman Clinical Trials Market Estimates and Forecasts, by Study Design, 2021-2033 (USD Million)
Table 31 Oman Clinical Trials Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 32 Oman Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021-2033 (USD Million)
Table 33 Oman Clinical Trials Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 34 Oman Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021-2033 (USD Million)
Table 35 Qatar Clinical Trials Market Estimates and Forecasts, by Phase, 2021-2033 (USD Million)
Table 36 Qatar Clinical Trials Market Estimates and Forecasts, by Study Design, 2021-2033 (USD Million)
Table 37 Qatar Clinical Trials Market Estimates and Forecasts, by Indication, 2021-2033 (USD Million)
Table 38 Qatar Clinical Trials Market Estimates and Forecasts, Indication by Study Design, 2021-2033 (USD Million)
Table 39 Qatar Clinical Trials Market Estimates and Forecasts, by Service, 2021-2033 (USD Million)
Table 40 Qatar Clinical Trials Market Estimates and Forecasts, by Sponsor, 2021-2033 (USD Million)
List of Figures
Figure 1 Middle East Clinical Trials Market Segmentation
Figure 2 Market research process
Figure 3 Information Procurement
Figure 4 Primary Research Pattern
Figure 5 Market Research Approaches
Figure 6 Value Chain-Based Sizing & Forecasting
Figure 7 Market Formulation & Validation
Figure 8 Market Dynamics
Figure 9 Market Driver Relevance Analysis (Current & Future Impact)
Figure 10 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 11 Porter’s Five Forces Analysis
Figure 12 PESTEL by SWOT Analysis
Figure 13 Regional Marketplace: Key Takeaways
Figure 14 Phase I Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 15 Phase II Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 16 Phase III Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 17 Phase IV Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 18 Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 19 Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 20 Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 21 Autoimmune/Inflammation Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 22 Rheumatoid Arthritis Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 23 Multiple Sclerosis Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 24 Osteoarthritis Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 25 Irritable Bowel Syndrome (IBS) Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 26 Others Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 27 Pain Management Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 28 Chronic Pain Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 29 Acute Pain Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 30 Oncology Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 31 Blood Cancer Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 32 Solid Tumors Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 33 Others Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 34 CNS Conditions Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 35 Epilepsy Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 36 Parkinson's Disease (PD) Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 37 Huntington's Disease Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 38 Stroke Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 39 Traumatic Brain Injury (TBI) Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 40 Amyotrophic Lateral Sclerosis (ALS) Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 41 Muscle Regeneration Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 42 Others Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 43 Diabetes Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 44 Obesity Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 45 Cardiovascular Diseases Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 46 Others Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 47 Autoimmune/Inflammation Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 48 Autoimmune/Inflammation Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 49 Autoimmune/Inflammation Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 50 Pain Management Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 51 Pain Management Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 52 Pain Management Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 53 Oncology Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 54 Oncology Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 55 Oncology Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 56 CNS Conditions Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 57 CNS Conditions Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 58 CNS Conditions Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 59 Diabetes Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 60 Diabetes Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 61 Diabetes Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 62 Obesity Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 63 Obesity Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 64 Obesity Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 65 Cardiovascular Diseases Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 66 Cardiovascular Diseases Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 67 Cardiovascular Diseases Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 68 Others Interventional Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 69 Others Observational Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 70 Others Expanded Access Trials Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 71 Protocol Designing Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 72 Site Identification Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 73 Patient Recruitment Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 74 Laboratory Services Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 75 Analytical Testing Services Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 76 Clinical Trial Data Management Services Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 77 Others Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 78 Pharmaceutical & Biopharmaceutical Companies Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 79 Medical Device Companies Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 80 Others Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 81 Regional Outlook, 2024 & 2033
Figure 82 Middle East Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 83 South Africa Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 84 Saudi Arabia Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 85 UAE Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 86 Kuwait Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 87 Oman Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 88 Qatar Clinical Trials Market Estimates and Forecasts, 2021-2033 (USD Million)

Companies Mentioned

The leading players profiled in this Middle East Clinical Trials market report include:
  • Sanofi
  • Novartis AG
  • Pfizer
  • GSK plc
  • Novo Nordisk A/S
  • Hikma Pharmaceuticals PLC
  • Julphar
  • SPIMACO
  • Tabuk Pharmaceuticals
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson

Table Information

Report AttributeDetails
No. of Pages180
PublishedSeptember 2025
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 671.57 Million
Forecasted Market Value ( USD ) by 2033 $ 1160 Million
Compound Annual Growth Rate7.1%
Regions CoveredMiddle East
No. of Companies Mentioned12

Related Topics

Related Reports

Middle East Neurology Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), Study Design, Indication, Indication by Study Design, Indication by Phase, Value Chain, and Country with Growth Forecasts, 2025-2033 - Product Image

Middle East Neurology Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), Study Design, Indication, Indication by Study Design, Indication by Phase, Value Chain, and Country with Growth Forecasts, 2025-2033

  • Report
  • 120 Pages
  • Middle East
From
North America Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Indication by Study Design, By Service, By Sponsor, By Country, And Segment Forecasts, 2025 - 2033 - Product Image

North America Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication, By Indication by Study Design, By Service, By Sponsor, By Country, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • North America
From
U.S. Neurology Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design, by Indication, by Indication by Study Design, by Indication by Phase, by Value Chain, and Segment Forecasts, 2025-2033 - Product Image

U.S. Neurology Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Study Design, by Indication, by Indication by Study Design, by Indication by Phase, by Value Chain, and Segment Forecasts, 2025-2033

  • Report
  • 120 Pages
  • United States
From
Asia Pacific Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication, By Study Design, By Service, By Indication by Study Design, By Sponsor, By Country, And Segment Forecasts, 2025 - 2033 - Product Image

Asia Pacific Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication, By Study Design, By Service, By Indication by Study Design, By Sponsor, By Country, And Segment Forecasts, 2025 - 2033

  • Report
  • 80 Pages
  • Asia Pacific
From
Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III), By Indication (Oncology, Cardiology, CNS, Musculoskeletal, Infectious Diseases), By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Cell And Gene Therapy Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III), By Indication (Oncology, Cardiology, CNS, Musculoskeletal, Infectious Diseases), By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.